Kirchhof P - Search Results

1

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial.

Metzner A, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Kuck KH, Mont L, Ng GA, Szumowski L, Themistoclakis S, van Gelder IC, Vardas P, Wegscheider K, Willems S, Kirchhof P. Metzner A, et al. Among authors: kirchhof p. Europace. 2022 Apr 5;24(4):552-564. doi: 10.1093/europace/euab200. Europace. 2022. PMID: 34473249 Free PMC article. Clinical Trial.

2

Fetoscopic transesophageal electrocardiography and stimulation in fetal sheep: a minimally invasive approach aimed at diagnosis and termination of therapy-refractory supraventricular tachycardias in human fetuses.

Kohl T, Kirchhof PF, Gogarten W, Reckers J, Asfour B, Witteler R, Haverkamp W, Eckardt L, Marcus AE, VanAken H, Breithardt G, Vogt J, Scheld HH. Kohl T, et al. Among authors: kirchhof pf. Circulation. 1999 Aug 17;100(7):772-6. doi: 10.1161/01.cir.100.7.772. Circulation. 1999. PMID: 10449702

3

A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias.

Kirchhof P, Loh P, Eckardt L, Ribbing M, Rolf S, Eick O, Wittkampf F, Borggrefe M, Breithardt G Gü, Haverkamp W. Kirchhof P, et al. Am J Cardiol. 2002 Aug 1;90(3):340-3. doi: 10.1016/s0002-9149(02)02481-5. Am J Cardiol. 2002. PMID: 12127630 No abstract available.

4

[Atrial fibrillation: molecular biology bases].

Haverkamp W, Ammer R, Kirchhof P, Eckardt L, Fabritz L, Breithardt G. Haverkamp W, et al. Among authors: kirchhof p. Herz. 2002 Jun;27(4):301-5. doi: 10.1007/s00059-002-2368-5. Herz. 2002. PMID: 12187859 German.

5

Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.

Eckardt L, Bruns HJ, Paul M, Kirchhof P, Schulze-Bahr E, Wichter T, Breithardt G, Borggrefe M, Haverkamp W. Eckardt L, et al. Among authors: kirchhof p. J Cardiovasc Electrophysiol. 2002 Aug;13(8):742-9. doi: 10.1046/j.1540-8167.2002.00742.x. J Cardiovasc Electrophysiol. 2002. PMID: 12212690

6

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W. Milberg P, et al. Among authors: kirchhof p. J Pharmacol Exp Ther. 2002 Oct;303(1):218-25. doi: 10.1124/jpet.102.037911. J Pharmacol Exp Ther. 2002. PMID: 12235254

7

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial.

Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, Breithardt G, Haverkamp W, Borggrefe M. Kirchhof P, et al. Lancet. 2002 Oct 26;360(9342):1275-9. doi: 10.1016/s0140-6736(02)11315-8. Lancet. 2002. PMID: 12414201 Clinical Trial.

8

Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.

Fabritz L, Kirchhof P, Franz MR, Eckardt L, Mönnig G, Milberg P, Breithardt G, Haverkamp W. Fabritz L, et al. Among authors: kirchhof p. Basic Res Cardiol. 2003 Feb;98(1):25-32. doi: 10.1007/s00395-003-0386-y. Basic Res Cardiol. 2003. PMID: 12494266

9

Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.

Kirchhof P, Degen H, Franz MR, Eckardt L, Fabritz L, Milberg P, Läer S, Neumann J, Breithardt G, Haverkamp W. Kirchhof P, et al. J Pharmacol Exp Ther. 2003 Apr;305(1):257-63. doi: 10.1124/jpet.102.046755. J Pharmacol Exp Ther. 2003. PMID: 12649377

10

Effect of sotalol and acute ventricular dilatation on action potential duration and dispersion of repolarization after defibrillation shocks.

Kirchhof P, Milberg P, Eckardt L, Breithardt G, Haverkamp W. Kirchhof P, et al. J Cardiovasc Pharmacol. 2003 Apr;41(4):640-8. doi: 10.1097/00005344-200304000-00018. J Cardiovasc Pharmacol. 2003. PMID: 12658067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

660 results

Search Page